Company Description:
Building Products & Materials Firm
Building Products & Materials Firm
Construction Executive Online
Construction Job Openings
Company News
- Major 2024 licensing deals confirm Asia’s ascent from copier to innovator - BioWorld MedTech (news.google.com)
- Merck snags Chinese cancer drug for up to US$3.3 billion - The Business Times (news.google.com)
- Merck Snags Chinese Cancer Drug For Up to $3.3 Billion - BNN Bloomberg (news.google.com)
- Merck Announces Third-Quarter 2024 Financial Results - Business Wire (news.google.com)
- MSD acquires B-Cell depletion therapy CN201 from Curon Biopharmaceutical in $1.3B deal - European Pharmaceutical Manufacturer (news.google.com)
- China Health Stocks Tipped for Rebound on Valuations, Fed Rate Cut Bets - Bloomberg.com (news.google.com)
- Merck secures antibody in $700m Curon deal - BioProcess International (news.google.com)
- Merck Strikes $1.3 Billion Deal to Acquire Curon’s B-Cell Therapy Drug - geneonline.com (news.google.com)
- MSD adds bispecific cancer antibody via $1.3bn Curon deal - pharmaphorum (news.google.com)
- MSD acquires Curon’s CD3 x CD19 bispecific antibody for up to $1.3B - BioWorld MedTech (news.google.com)
- Merck to Acquire B-Cell Depletion Candidate from Curon - Contract Pharma (news.google.com)
- Merck to Acquire Investigational B-Cell Depletion Therapy, CN201, from Curon Biopharmaceutical - Business Wire (news.google.com)
- Merck Steps Into CD19 Bispecific Antibody Ring With Curon Deal - insights.citeline.com (news.google.com)
- MSD sets sights on bispecific antibody market with Curon acqusition - Pharmaceutical Technology (news.google.com)
- Merck bets $700M on an antibody drug’s potential in immune diseases - BioPharma Dive (news.google.com)
- Merck Puts Up Potential $1.3B to Acquire Curon’s B Cell Depletion Therapy - BioSpace (news.google.com)
- Lost worlds, submerged stories unfurl in Italy's Curon Venosta | Daily Sabah - Daily Sabah (news.google.com)
- Speaker - Financial Executives International (news.google.com)
- ‘Sinking’ town’s stunning find after 70 yrs - News.com.au (news.google.com)
- The village of Curon, Italy’s own real-life Atlantis - Deseret News (news.google.com)
- Curon: Italian lake reveals lost underwater village - Wanted in Milan (news.google.com)
- Rhizen Pharmaceuticals S.A. and Curon Biopharmaceutical Limited Announce an Exclusive Licensing Agreement to Develop and Commercialize Tenalisib, a Dual PI3K Delta and Gamma Inhibitor for Oncology in Greater China - GlobeNewswire (news.google.com)
- Curon Review: Be Scared To Watch This Italian Horror Because It Bores You To Death - Koimoi (news.google.com)
- Curon review – enjoy your stay with Netflix’s new supernatural thriller - Ready Steady Cut (news.google.com)
- MSD sues German Merck for using name in US - Pharmafile (news.google.com)
- COMPANY PROFILE: The secrets of that Merck rebrand - Pharmafile (news.google.com)
- Pfizer cuts manufacturing again with plant closure - Pharmafile (news.google.com)
- Caelyx rights to revert back to Janssen - Pharmafile (news.google.com)